EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evaluation of Phenotypic Tests to Detect Extended-Spectrum β-Lactamase (ESBL)-Producing Klebsiella oxytoca Complex Strains

Edgar I Campos-Madueno iD, Aline I Moser, Peter M Keller, Vincent Perreten iD, Laurent Poirel iD, Patrice Nordmann iD, Andrea Endimiani iD

Journal of Clinical Microbiology · 2023

DOI: 10.1128/jcm.01706-22 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Microbiology, 2023. Verfasst von Edgar I Campos-Madueno und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Infectious Diseases, University of Bern, Bern, Switzerland. Hauptthemen laut MEDLINE: Ceftazidime, Klebsiella oxytoca. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Klebsiella oxytoca complex ( Ko C) species may overproduce their chromosomal class A OXY β-lactamases, conferring reduced susceptibility to piperacillin-tazobactam, expanded-spectrum cephalosporins and aztreonam. Moreover, since clavulanate maintains its ability to inhibit these enzymes, the resulting resistance phenotype may falsely resemble the production of acquired extended-spectrum β-lactamases (ESBLs).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CeftazidimeKlebsiella oxytocaHumansCefepimeAnti-Bacterial AgentsCephalosporinsbeta-LactamasesClavulanic AcidPiperacillin, Tazobactam Drug CombinationPhenotypeMicrobial Sensitivity TestsKlebsiella pneumoniae

Stichwörter der Autor:innen

CDTCTX-MDDSTESBLKlebsiella oxytocaOXYavibactamclavulanateconfirmatory testdetection

Substanzen

CeftazidimeCefepimeAnti-Bacterial AgentsCephalosporinsbeta-LactamasesClavulanic AcidPiperacillin, Tazobactam Drug Combination

Autor:innen und Institutionen

  • Institute for Infectious Diseases, University of Bern, Bern, Switzerland.
  • Graduate School of Cellular and Biomedical Sciences, University of Bern, Bern, Switzerland.
  • Institute of Veterinary Bacteriology, University of Bern, Bern, Switzerland.
  • Medical and Molecular Microbiology, Department of Medicine, University of Fribourg, Fribourg, Switzerland.
  • National Reference Center for Emerging Antibiotic Resistance (NARA), Fribourg, Switzerland.

ORCID-Profile: Edgar I Campos-Madueno, Vincent Perreten, Laurent Poirel, Patrice Nordmann, Andrea Endimiani

Förderung

  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung

Zitieren

APA

Campos-Madueno, E. I., Moser, A. I., Keller, P. M., Perreten, V., Poirel, L., Nordmann, P., & Endimiani, A. (2023). Evaluation of Phenotypic Tests to Detect Extended-Spectrum β-Lactamase (ESBL)-Producing Klebsiella oxytoca Complex Strains. Journal of Clinical Microbiology. https://doi.org/10.1128/jcm.01706-22

Vancouver

Campos-Madueno EI, Moser AI, Keller PM, Perreten V, Poirel L, Nordmann P, et al. Evaluation of Phenotypic Tests to Detect Extended-Spectrum β-Lactamase (ESBL)-Producing Klebsiella oxytoca Complex Strains. Journal of Clinical Microbiology. 2023. doi:10.1128/jcm.01706-22

BibTeX
@article{CamposMadueno2023,
  author = {Campos-Madueno, Edgar I and Moser, Aline I and Keller, Peter M and Perreten, Vincent and Poirel, Laurent and Nordmann, Patrice and Endimiani, Andrea},
  title = {Evaluation of Phenotypic Tests to Detect Extended-Spectrum β-Lactamase (ESBL)-Producing Klebsiella oxytoca Complex Strains},
  journal = {Journal of Clinical Microbiology},
  year = {2023},
  doi = {10.1128/jcm.01706-22}
}
Kostenlos starten →